The Valley Desk

NCT03292406 · Interventional trial

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

Overall registry status Completed

Phase 2

Conditions Cutaneous T Cell Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov